CLINICAL TRIALS PROFILE FOR OLICERIDINE
✉ Email this page to a colleague
All Clinical Trials for oliceridine
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02656875 ↗ | A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain | Completed | Trevena Inc. | Phase 3 | 2015-12-01 | Patients with moderate to severe pain caused by medical conditions or surgery, who require IV opioid therapy may be enrolled in this open label safety study. Patients will be treated with TRV130 by IV bolus, PCA (patient-controlled analgesia) administration, or both, as determined by the investigator, for a duration not to exceed 14 days. |
| NCT02815709 ↗ | Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy | Completed | Trevena Inc. | Phase 3 | 2016-05-01 | The primary objective is to evaluate the analgesic efficacy of intravenous (IV) oliceridine administered as needed (PRN) compared with placebo in patients with moderate to severe acute postoperative pain after bunionectomy. |
| NCT02820324 ↗ | Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty | Completed | Trevena Inc. | Phase 3 | 2016-05-01 | The primary objective is to evaluate the analgesic efficacy of intravenous (IV) oliceridine administered as needed (PRN) compared with placebo in patients with moderate to severe acute pain after abdominoplasty. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for oliceridine
Condition Name
Clinical Trial Locations for oliceridine
Trials by Country
Clinical Trial Progress for oliceridine
Clinical Trial Phase
Clinical Trial Sponsors for oliceridine
Sponsor Name
